Knockback for drug to treat patients with relapsed or refractory multiple myeloma
A Swedish biotech company says it believes its treatment could be the ‘canary in the…
September 23, 2022 - 3 minutes
Multiple myeloma
Collaboration to explore gene therapy products for neurodegenerative disorders
Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop…
September 14, 2022 - 3 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
January 28, 2019 - 3 minutes
Genmab and Janssen Suffer Combination Therapy Setback
Janssen will discontinue a Phase I study testing Danish biotech Genmab's blood cancer blockbuster daratumumab…
May 28, 2018 - 2 minutes
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
December 18, 2017 - 9 minutes
Welcome to the Blockbuster Club, Genmab!
Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a…
November 17, 2017 - 3 minutes
Swedish Oncology Biotech makes a Large IPO for its Peptides
The Swedish company Oncopeptides raised €68M with its IPO on Nasdaq Stockholm, which will allow…
March 1, 2017 - 3 minutes
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
What are the most impressive advances in medical biotechnology this year? From cancer to peanut…
December 22, 2016 - 5 minutes
How is European Immuno-Oncology fighting Blood Cancer?
From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year's…
December 6, 2016 - 4 minutes
Spain joins the Antibody-Drug Conjugate Bandwagon to fight Cancer
PharmaMar announced positive preclinical results for an ADC candidate, showing that the traditional chemistry-based pharma…
December 1, 2016 - 2 minutes
Celyad’s Autologous CAR-T Therapy enters Phase Ib
Celyad has received approval to start Phase Ib trials in Belgium with its autologous CAR-T…
November 21, 2016 - 2 minutes
TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer
Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some…
October 28, 2016 - 2 minutes
